News Focus
News Focus
Followers 53
Posts 6781
Boards Moderated 0
Alias Born 02/13/2012

Re: ATLnsider post# 602910

Tuesday, 06/20/2023 2:59:52 AM

Tuesday, June 20, 2023 2:59:52 AM

Post# of 822110
Thanks. Past day a great deal of good information. Especially on tissue agnostic. Keytruda had to do POST APPROVAL studies. A great deal better than full blown trials. That is what I expected.

Once you are making money, collecting data on people using it at some centers gets much easier.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News